Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Phylex Vaccine On Track To Combat Deadly NIPAH Virus With Positive Results Of Immunogenicity Study

Phylex Biosciences has achieved positive results with its new mRNA nanoparticle vaccine against the Nipah virus in an immunogenicity study conducted in collaboration with scientists of the U.S. Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.

August 6, 2024


September 10 2024

September 9 2024

September 8 2024

September 7 2024

September 6 2024

September 5 2024

September 4 2024

September 3 2024

September 2 2024

September 1 2024

August 31 2024

August 30 2024

August 29 2024

August 28 2024